Use of FDG-PET/CT to Predict Immunotherapy Treatment Response in Patients With OCSCC

xlomafota13 shared this article with you from Inoreader Use of FDG-PET/CT to Predict Immunotherapy Treatment Response in Patients With OCSCC Via JAMA Otolaryngology–Head & Neck Surgery Online First This study assesses whether there are changes on fluoro-[18F]- deoxy-2-D-glucose positron emission tomography/computed tomography scans in patients with oral cavity squamous cell cancer receiving neoadjuvant immunotherapy. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.